000			01346nam a22002057a 4500
003			KENaKMTC
005			20230414094845.0
008			230414b ||||| |||| 00| 0 eng d
020			_a9789241209816
040			_cDLC
050			_aRS189 _b.W67 2013
110			_aWorld Health Organization
245			_aWho Expert Committee on Specifications for Pharmaceutical Preparations : _bforty-seventh report/
260			_aGeneva _bWorld Health Organization _cc2013
300			_axi, 188p.: _bill.; _c24cm.
505			_a Introduction General policy Quality control: specifications and tests Quality control: international reference materials (International Chemical Reference Substances and International Infrared Reference Spectra) Quality control: national laboratories Quality assurance: good manufacturing practices Quality assurance: new approaches Quality assurance: distribution and trade of pharmaceuticals Prequalification of priority essential medicines including active pharmaceutical ingredients Prequalification of active pharmaceutical ingredients Prequalification of quality control laboratories Regulatory guidance Nomenclature, terminology and databases Miscellaneous Summary and recommendations Annexes
650			_aDRUG FORMS + DOSAGE FORMS (PHARMACY)
650			_aDrugs Quality control
942			_2lcc _cBK _xLL
999			_c19861 _d19861